OR52N5

Across TCGA pan-cancer cohorts, OR52N5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR52N5’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where OR52N5 RNA is repressed in tumor relative to normal tissue. In most cancer types OR52N5 is over-expressed in tumor, although a few such as PAAD and LUSC show the opposite, repressed pattern.

PAAD, LUSC, and LIHC are the cancer types where OR52N5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52N5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Male	All	−0.095	.002	2	view →
LUSC	All	II,III,IV	−0.062	.027	1	view →
LIHC	All	All	+0.020	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR52N5–PAAD

Open the PAAD breakdown →